QUALITATIVE EXPLORATION OF THE REAL-WORLD EXPERIENCES OF MEN RECEIVING OR REFUSING CHEMOTHERAPY (DOCETAXEL) FOR THE TREATMENT OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)

被引：0
|
作者：
Ito, T. [1 ]
Grant, L. [2 ]
Mills, A. [3 ]
Heselwood, A. [3 ]
Gater, A. [2 ]
机构：
[1] Janssen Cilag UK, High Wycombe, Bucks, England
[2] Adelphi Values Ltd, Bollington, Cheshire, England
[3] Adelphi Res UK, Bollington, Cheshire, England
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.295
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN212
引用
收藏
页码：A450 / A450
页数：1
相关论文
共 50 条
  • [41] Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC)
    Custodio-Cabello, Sara
    Pacheco-Barcia, Vilma
    Palka-Kotlowska, Magda
    Fernandez-Hernandez, Laura
    Del Alamo, Julio Fernandez
    Oliveros-Acebes, Eduardo
    Cabezon-Gutierrez, Luis
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (10) : 331e13 - 331e24
  • [42] Treatment of metastatic hormone-sensitive prostate cancer
    Rane, Jayant K.
    Chowdhury, Amani
    Kinnaird, William
    Marks, Gillian
    Davda, Reena
    TRENDS IN UROLOGY & MENS HEALTH, 2021, 12 (06) : 7 - 10
  • [43] Comment on Real-world Efficacy and Toxicity Analysis of Abiraterone Acetate versus Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer in Asian Patients
    Sudhakaran, Gokul
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [44] Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database
    Eule, Corbin J.
    Kuna, Elizabeth Molina
    Robin, Tyler P.
    Gershman, Boris
    Flaig, Thomas W.
    Kim, Simon P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 447e17 - 447e24
  • [45] Assessment of whether time to docetaxel impacts outcome when given in metastatic hormone-sensitive prostate cancer (MHSPC) setting
    George, S.
    Gosain, R.
    Yendamuri, K.
    Boher, J. M.
    Mescam, G. Gravis
    Sweeney, C. J.
    Hutson, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1168 - S1169
  • [46] Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study
    Kafka, Mona
    Giannini, Giulia
    Artamonova, Nastasiia
    Neuwirt, Hannes
    Ofner, Heidemarie
    Kramer, Gero
    Bauernhofer, Thomas
    Luger, Ferdinand
    Hoefner, Thomas
    Loidl, Wolfgang
    Griessner, Hubert
    Lusuardi, Lukas
    Bergmaier, Antonia
    Berger, Andreas
    Winder, Thomas
    Weiss, Sarah
    Bauinger, Severin
    Krause, Steffen
    Drerup, Martin
    Heinrich, Elmar
    Schneider, Magdalena
    Madersbacher, Stephan
    Vallet, Sonia
    Stoiber, Franz
    Laimer, Sarah
    Hruby, Stephan
    Schachtner, Gert
    Nagele, Udo
    Lenart, Sebastian
    Ponholzer, Anton
    Pfuner, Jacob
    Wiesinger, Clemens
    Kamhuber, Christoph
    Muelduer, Ecan
    Bektic, Jasmin
    Horninger, Wolfgang
    Heidegger, Isabel
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 458 - 466.e1
  • [47] Impact of prior definitive therapy on survival outcomes in men with new hormone-sensitive metastatic prostate cancer (mHSPC).
    Alex, Anitha
    Stenehjem, David D.
    Twardowski, Przemyslaw
    Cheng, Heather H.
    Gill, David Michael
    Buckley, Tyler Howard
    Patel, Shiven B.
    Kessler, Elizabeth Riley
    Chittoria, Namita
    Poudel, Aarati
    Vaishampayan, Ulka N.
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
    Kenrick Ng
    Shievon Smith
    Jonathan Shamash
    Oncology and Therapy, 2020, 8 : 209 - 230
  • [49] Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
    Ng, Kenrick
    Smith, Shievon
    Shamash, Jonathan
    ONCOLOGY AND THERAPY, 2020, 8 (02) : 209 - 230
  • [50] Triplet therapy in metastatic hormone-sensitive prostate cancer: A real-world Indian multicentre study.
    Mondal, Debapriya
    Roy, Somnath
    Bhattacharjee, Arnab
    Roy, Rakesh
    Meyur, Suman
    Biswas, Bivas
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345